Name | Value |
---|---|
Revenues | 221.2M |
Cost of Revenue | 82.8M |
Gross Profit | 138.4M |
Operating Expense | 133.6M |
Operating I/L | -1.6M |
Other Income/Expense | 8.7M |
Interest Income | 0.3M |
Pretax | 7.1M |
Income Tax Expense | 3.3M |
Net Income/Loss | 3.9M |
Penumbra, Inc. is a global medical device company specializing in the design, development, manufacturing, and marketing of a wide range of neurovascular and vascular medical devices. The company's product portfolio includes aspiration-based thrombectomy systems, neurovascular embolization coiling systems, neurovascular access systems, neurosurgical aspiration tools, detachable embolic coil systems, microcatheters, occlusion devices, and immersive computer-based technologies. Penumbra generates revenue through the sale of its medical devices, which are used in various neurovascular and vascular therapies, and are distributed through direct sales organizations and distributors.